Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept

Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept

Myelodysplastic syndromes (MDS) are a group of clonal myeloid disorders distinguished by dysplastic bone marrow and peripheral blood cells, ineffective hematopoiesis, and an increased risk of developing acute myeloid leukemia (AML). MDS with ring sideroblasts (MDS-RS) is a favorable outcome subtype...

Full description

Bibliographic Details
Main Authors: Sigurd Delanghe, Tri Q. Nguyen, Dominiek Mazure, Amélie Dendooven, Marijn M. Speeckaert
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Diagnostics
Subjects:
myelodysplastic syndrome with ring sideroblasts
acute kidney injury
immune-complex-mediated proliferative glomerulonephritis
transforming growth factor-beta
Smads
Online Access:https://www.mdpi.com/2075-4418/13/1/11

Internet

https://www.mdpi.com/2075-4418/13/1/11

Similar Items